Ayala Pharmaceuticals Inc (ADXS): Actually, AZN has the right of first neg...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	827
Posts	119564
Boards Moderated	15
Alias Born	09/05/2002

DewDiligence

Re: ignatiusrielly35 post# 11557

Monday, 01/23/2017 2:39:20 PM

Monday, January 23, 2017 2:39:20 PM

Actually, AZN has the right of first negotiation (not the right of first refusal) on development of the AXAL/durvalumab combination; from page F-22 of ADXS’ 10-K filing:

https://www.sec.gov/Archives/edgar/data/1100397/000149315217000250/form10-k.htm

For a period beginning upon the completion of the study and the receipt by MedImmune of the last final report for the study and ending one hundred twenty (120) days thereafter (unless extended), MedImmune will be granted first right to negotiate in good faith in an attempt to enter into an agreement with us with respect to the development, regulatory approval and commercialization of AXAL and MEDI4736 [Durvalumab] to be used in combination with each other for the treatment or prevention of cancer.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”